| Hepatocellular Carcinoma altered in cohorts of …ALTERED_INderived200 of 214show all (up to 200) |
|---|
| ← altered in cohorts of | ASH1L 279 / 377 cases (74 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RUSC1 277 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EFNA3 276 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM189B 276 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PKLR 276 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC50A1 276 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | THBS3 276 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADAM15 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CLK2 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DCST2 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EFNA1 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FDPS 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INSRR 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTX1 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCAMP3 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIM46 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBTB7B 275 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARHGEF2 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DCST1 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DPM3 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EFNA4 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GBA 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HCN3 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KHDC4 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KRTCAP2 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LENEP 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MUC1 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | YY1AP1 274 / 377 cases (73 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CKS1B 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DAP3 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FLAD1 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FLG 273 / 377 cases (72 %) · ssm · TCGA-LIHC · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | GON4L 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MSTO1 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PBXIP1 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PYGO2 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RIT1 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RXFP4 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHC1 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC27A3 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SMG5 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYT11 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNN 273 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IQGAP3 272 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LMNA 272 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MEX3A 272 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PMVK 272 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BCAN 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BMP1 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCT3 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHRNB2 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CRTC2 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DENND4B 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ETV3L 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FCRL5 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GATAD2B 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ISG20L2 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNN3 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LAMTOR2 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC71 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MNDA 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NES 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NPR1 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NTRK1 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIWIL2 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PMF1 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POLR3D 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAB25 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SEMA4A 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SH2D2A 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SSR2 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STYXL2 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM79 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFRSF10A 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBAP2L 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBE2Q1 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBQLN4 271 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADAM28 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARHGAP30 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATF6 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP8B2 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CRABP2 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CREB3L4 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ETV3 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FCGR3B 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GLMP 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HAPLN2 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HDGF 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NIT1 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR6Y1 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PAQR6 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PEAR1 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | REEP4 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNAPIN 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | USP21 270 / 377 cases (72 %) · ssm · TCGA-LIHC | — | — | Hepatocellular Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTN 177 / 494 cases (36 %) · ssm · hcc_clca_2024 · largest of 7 cohorts | — | — | Hepatocellular Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 466 / 1,370 cases (34 %) · ssm · hcc_msk_2024 · largest of 10 cohorts | — | — | Hepatocellular Carcinoma | 10 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 105 / 494 cases (21 %) · ssm · hcc_clca_2024 · largest of 6 cohorts | — | — | Hepatocellular Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1A 226 / 1,370 cases (16 %) · ssm · hcc_msk_2024 · largest of 8 cohorts | — | — | Hepatocellular Carcinoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TERT 225 / 1,370 cases (16 %) · ssm · hcc_msk_2024 · largest of 5 cohorts | — | — | Hepatocellular Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ALB 73 / 494 cases (15 %) · ssm · hcc_clca_2024 · largest of 5 cohorts | — | — | Hepatocellular Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCLO 67 / 494 cases (14 %) · ssm · hcc_clca_2024 · largest of 7 cohorts | — | — | Hepatocellular Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 65 / 494 cases (13 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 60 / 494 cases (12 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP1B 59 / 494 cases (12 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 59 / 494 cases (12 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN1 58 / 494 cases (12 %) · ssm · hcc_clca_2024 · largest of 5 cohorts | — | — | Hepatocellular Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AXIN1 57 / 494 cases (12 %) · ssm · hcc_clca_2024 · largest of 5 cohorts | — | — | Hepatocellular Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 57 / 494 cases (12 %) · ssm · hcc_clca_2024 · largest of 5 cohorts | — | — | Hepatocellular Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KRAS 152 / 1,370 cases (11 %) · ssm · hcc_msk_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APOB 54 / 494 cases (11 %) · ssm · hcc_clca_2024 · largest of 5 cohorts | — | — | Hepatocellular Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCA13 53 / 494 cases (11 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1L1 52 / 494 cases (11 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FBN2 51 / 494 cases (10 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IDH1 141 / 1,370 cases (10 %) · ssm · hcc_msk_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT3 50 / 494 cases (10 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CTNNB1 132 / 1,370 cases (9.6 %) · ssm · hcc_msk_2024 · largest of 10 cohorts | — | — | Hepatocellular Carcinoma | 10 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 47 / 494 cases (9.5 %) · ssm · hcc_clca_2024 · largest of 5 cohorts | — | — | Hepatocellular Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR3 47 / 494 cases (9.5 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HYDIN 21 / 231 cases (9.1 %) · ssm · lihc_amc_prv | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD1 43 / 494 cases (8.7 %) · ssm · hcc_clca_2024 · largest of 6 cohorts | — | — | Hepatocellular Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 43 / 494 cases (8.7 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BAP1 117 / 1,370 cases (8.5 %) · ssm · hcc_msk_2024 · largest of 3 cohorts | — | — | Hepatocellular Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD2 41 / 494 cases (8.3 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 41 / 494 cases (8.3 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | XIRP2 41 / 494 cases (8.3 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTA1 40 / 494 cases (8.1 %) · ssm · hcc_clca_2024 · largest of 5 cohorts | — | — | Hepatocellular Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC17 39 / 494 cases (7.9 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMAD4 103 / 1,370 cases (7.5 %) · ssm · hcc_msk_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH10 37 / 494 cases (7.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EYS 37 / 494 cases (7.5 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC2H1 36 / 494 cases (7.3 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FRAS1 36 / 494 cases (7.3 %) · ssm · hcc_clca_2024 · largest of 3 cohorts | — | — | Hepatocellular Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA1 36 / 494 cases (7.3 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RB1 36 / 494 cases (7.3 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL11A1 35 / 494 cases (7.1 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH8 35 / 494 cases (7.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA2 35 / 494 cases (7.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK2 26 / 373 cases (7.0 %) · ssm · lihc_tcga · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PBRM1 95 / 1,370 cases (6.9 %) · ssm · hcc_msk_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC80 34 / 494 cases (6.9 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC4 25 / 373 cases (6.7 %) · ssm · lihc_tcga | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH7 33 / 494 cases (6.7 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 32 / 494 cases (6.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRP2 32 / 494 cases (6.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 32 / 494 cases (6.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SACS 32 / 494 cases (6.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC13C 32 / 494 cases (6.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ALMS1 24 / 373 cases (6.4 %) · ssm · lihc_tcga | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH6 24 / 373 cases (6.4 %) · ssm · lihc_tcga | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CUBN 31 / 494 cases (6.3 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DSCAM 31 / 494 cases (6.3 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 31 / 494 cases (6.3 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO18B 31 / 494 cases (6.3 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TSC2 31 / 494 cases (6.3 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF804B 31 / 494 cases (6.3 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CFAP54 30 / 494 cases (6.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL12A1 30 / 494 cases (6.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A3 30 / 494 cases (6.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH17 30 / 494 cases (6.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT2 30 / 494 cases (6.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRUNE2 30 / 494 cases (6.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SCN1A 30 / 494 cases (6.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPEG 30 / 494 cases (6.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TENM4 30 / 494 cases (6.1 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADAMTS20 29 / 494 cases (5.9 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID2 29 / 494 cases (5.9 %) · ssm · hcc_clca_2024 · largest of 3 cohorts | — | — | Hepatocellular Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1E 29 / 494 cases (5.9 %) · ssm · hcc_clca_2024 · largest of 5 cohorts | — | — | Hepatocellular Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DOCK2 29 / 494 cases (5.9 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EPB41L3 29 / 494 cases (5.9 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FSIP2 29 / 494 cases (5.9 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 29 / 494 cases (5.9 %) · ssm · hcc_clca_2024 · largest of 3 cohorts | — | — | Hepatocellular Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBEA 29 / 494 cases (5.9 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE2 29 / 494 cases (5.9 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRKDC 21 / 370 cases (5.7 %) · ssm · hcc_tcga_gdc · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL6A5 28 / 494 cases (5.7 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL7A1 28 / 494 cases (5.7 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | JAK1 28 / 494 cases (5.7 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRRIQ1 28 / 494 cases (5.7 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PREX2 28 / 494 cases (5.7 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROBO2 28 / 494 cases (5.7 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WDFY4 28 / 494 cases (5.7 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF469 28 / 494 cases (5.7 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BIRC6 21 / 373 cases (5.6 %) · ssm · lihc_tcga | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DSPP 21 / 373 cases (5.6 %) · ssm · lihc_tcga | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ACAN 27 / 494 cases (5.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH18 27 / 494 cases (5.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH9 27 / 494 cases (5.5 %) · ssm · hcc_clca_2024 · largest of 2 cohorts | — | — | Hepatocellular Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FREM1 27 / 494 cases (5.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KEAP1 27 / 494 cases (5.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | STAB2 27 / 494 cases (5.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF831 27 / 494 cases (5.5 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WDR87 20 / 366 cases (5.5 %) · ssm · lihc_tcga_pan_can_atlas_2018 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PCDH15 20 / 370 cases (5.4 %) · ssm · hcc_tcga_gdc | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATM 74 / 1,370 cases (5.4 %) · ssm · hcc_msk_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DMD 20 / 373 cases (5.4 %) · ssm · lihc_tcga · largest of 3 cohorts | — | — | Hepatocellular Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HERC2 20 / 373 cases (5.4 %) · ssm · lihc_tcga · largest of 3 cohorts | — | — | Hepatocellular Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC2 20 / 373 cases (5.4 %) · ssm · lihc_tcga | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATP10B 26 / 494 cases (5.3 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CACNA1G 26 / 494 cases (5.3 %) · ssm · hcc_clca_2024 | — | — | Hepatocellular Carcinoma | 1 | Observed | cbioportal | graph → |